BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 24784886)

  • 1. Silencing of PKCη induces cycle arrest of EBV(+) B lymphoma cells by upregulating expression of p38-MAPK/TAp73/GADD45α and increases susceptibility to chemotherapeutic agents.
    Park GB; Choi Y; Kim YS; Lee HK; Kim D; Hur DY
    Cancer Lett; 2014 Aug; 350(1-2):5-14. PubMed ID: 24784886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligation of CD47 induces G1 arrest in EBV-transformed B cells through ROS generation, p38 MAPK/JNK activation, and Tap73 upregulation.
    Park GB; Bang SR; Lee HK; Kim D; Kim S; Kim JK; Kim YS; Hur DY
    J Immunother; 2014; 37(6):309-20. PubMed ID: 24911792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential treatment of HPV E6 and E7-expressing TC-1 cells with bortezomib and celecoxib promotes apoptosis through p-p38 MAPK-mediated downregulation of cyclin D1 and CDK2.
    Kim JE; Lee JI; Jin DH; Lee WJ; Park GB; Kim S; Kim YS; Wu TC; Hur DY; Kim D
    Oncol Rep; 2014 May; 31(5):2429-37. PubMed ID: 24627094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melphalan-induced apoptosis of EBV-transformed B cells through upregulation of TAp73 and XAF1 and nuclear import of XPA.
    Park GB; Kim YS; Kim D; Kim S; Lee HK; Cho DH; Lee WJ; Hur DY
    J Immunol; 2013 Dec; 191(12):6281-91. PubMed ID: 24249729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PKCeta enhances cell cycle progression, the expression of G1 cyclins and p21 in MCF-7 cells.
    Fima E; Shtutman M; Libros P; Missel A; Shahaf G; Kahana G; Livneh E
    Oncogene; 2001 Oct; 20(46):6794-804. PubMed ID: 11709714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt's lymphoma cells depending on viral latency program.
    De Leo A; Arena G; Stecca C; Raciti M; Mattia E
    Mol Cancer Res; 2011 Oct; 9(10):1346-55. PubMed ID: 21856773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bortezomib induces G2-M arrest in human colon cancer cells through ROS-inducible phosphorylation of ATM-CHK1.
    Hong YS; Hong SW; Kim SM; Jin DH; Shin JS; Yoon DH; Kim KP; Lee JL; Heo DS; Lee JS; Kim TW
    Int J Oncol; 2012 Jul; 41(1):76-82. PubMed ID: 22552540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoic acid-mediated growth arrest of EBV-immortalized B lymphocytes is associated with multiple changes in G1 regulatory proteins: p27Kip1 up-regulation is a relevant early event.
    Zancai P; Cariati R; Rizzo S; Boiocchi M; Dolcetti R
    Oncogene; 1998 Oct; 17(14):1827-36. PubMed ID: 9778049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bortezomib induces apoptosis of Epstein-Barr virus (EBV)-transformed B cells and prolongs survival of mice inoculated with EBV-transformed B cells.
    Zou P; Kawada J; Pesnicak L; Cohen JI
    J Virol; 2007 Sep; 81(18):10029-36. PubMed ID: 17626072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of SAHA and bortezomib up-regulates CDKN2A and CDKN1A and induces apoptosis of Epstein-Barr virus-positive Wp-restricted Burkitt lymphoma and lymphoblastoid cell lines.
    Hui KF; Leung YY; Yeung PL; Middeldorp JM; Chiang AK
    Br J Haematol; 2014 Dec; 167(5):639-50. PubMed ID: 25155625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer cells are arrested at different phases of the cell cycle following the re-expression of ARHI.
    Zuo X; Qin Y; Zhang X; Ning Q; Shao S; Luo M; Yuan N; Huang S; Zhao X
    Oncol Rep; 2014 May; 31(5):2358-64. PubMed ID: 24676336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulated A20 promotes proliferation, regulates cell cycle progression and induces chemotherapy resistance of acute lymphoblastic leukemia cells.
    Chen S; Xing H; Li S; Yu J; Li H; Liu S; Tian Z; Tang K; Rao Q; Wang M; Wang J
    Leuk Res; 2015 Sep; 39(9):976-83. PubMed ID: 26159495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of p21(Waf1/Cip1) by garcinol via downregulation of p38-MAPK signaling in p53-independent H1299 lung cancer.
    Yu SY; Liao CH; Chien MH; Tsai TY; Lin JK; Weng MS
    J Agric Food Chem; 2014 Mar; 62(9):2085-95. PubMed ID: 24533688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAp73-mediated the activation of c-Jun N-terminal kinase enhances cellular chemosensitivity to cisplatin in ovarian cancer cells.
    Zhang P; Liu SS; Ngan HY
    PLoS One; 2012; 7(8):e42985. PubMed ID: 22900074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monensin-mediated growth inhibition in NCI-H929 myeloma cells via cell cycle arrest and apoptosis.
    Park WH; Kim ES; Kim BK; Lee YY
    Int J Oncol; 2003 Jul; 23(1):197-204. PubMed ID: 12792794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Berberine induces mitochondrial apoptosis of EBV-transformed B cells through p53-mediated regulation of XAF1 and GADD45α.
    Park GB; Park SH; Kim D; Kim YS; Yoon SH; Hur DY
    Int J Oncol; 2016 Jul; 49(1):411-21. PubMed ID: 27121748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactive oxygen species-mediated activation of the Akt/ASK1/p38 signaling cascade and p21(Cip1) downregulation are required for shikonin-induced apoptosis.
    Ahn J; Won M; Choi JH; Kim YS; Jung CR; Im DS; Kyun ML; Lee K; Song KB; Chung KS
    Apoptosis; 2013 Jul; 18(7):870-81. PubMed ID: 23546866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decitabine, a DNA methyltransferases inhibitor, induces cell cycle arrest at G2/M phase through p53-independent pathway in human cancer cells.
    Shin DY; Sung Kang H; Kim GY; Kim WJ; Yoo YH; Choi YH
    Biomed Pharmacother; 2013 May; 67(4):305-11. PubMed ID: 23582784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Pleiotropic RNA-Binding Protein Controls Distinct Cell Cycle Checkpoints to Drive Resistance of p53-Defective Tumors to Chemotherapy.
    Cannell IG; Merrick KA; Morandell S; Zhu CQ; Braun CJ; Grant RA; Cameron ER; Tsao MS; Hemann MT; Yaffe MB
    Cancer Cell; 2015 Nov; 28(5):623-637. PubMed ID: 26602816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.